Head & Neck Cancer Awareness Month: US Patient Distributions – Geography, Age, Race, Gender & Income
White paper
Clinical
Head and neck cancer (HNC) was responsible for 3.7% of new US cancer cases in 2020, and the National Cancer Institute estimated that 16,110 people nationally would die from the condition in 2024. Smoking and alcohol consumption, advanced age, and infectious diseases such as HPV are risk factors for HNC.
About the author
Angelina Martella
Analyst II, Citeline
Angelina is a Sitetrove analyst specializing in oncology clinical trial site identification. Her deep understanding of client needs allows her to help clients optimize clinical trial site selection through the Ask the Analyst Service. With a B.A. in International Relations and a minor in Global Public Health from New York University, she leverages her analytical skills to visualize and interpret complex trial, patient, investigator, and drug data. Angelina has contributed to conference reports and white papers, particularly focusing on drug pipelines and non-small cell lung cancer.
